Development of biosimilars is costly, where glycan analysis a significant constraint on time and money. This paper provides an in-depth characterisation several novel recombinant prokaryotic lectins (RPLs), developed through directed evolution, displaying specific binding activities to ?-mannose, ?-galactose, fucose sialic acid residues, tested against major biosimilar targets. The all was perf...
